Welcome to our dedicated page for Pervasip news (Ticker: PVSP), a resource for investors and traders seeking the latest updates and insights on Pervasip stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Pervasip's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Pervasip's position in the market.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Pervasip Corp. (OTCPK: PVSP) is expanding into the Oregon recreational cannabis market through its subsidiary, Artizen Corporation. The Oregon cannabis industry generated $1.1 billion in sales in 2021 and hosts over 1,300 licensed cannabis businesses. Artizen will establish a wholly owned subsidiary, Artizen Oregon, operating a grow and processing facility in Ashland. This strategic location will facilitate potential future interstate operations. The company aims to harvest and distribute products by late summer 2023 with an initial production capacity limited to 280 lights. Pervasip's broader strategy includes connecting markets in Washington, Oregon, and California, which together generate approximately $6.5 billion in annual retail sales.
Pervasip Corp. (PVSP) announced its Q1 financial results for the period ending February 28, 2023. Key highlights include the transformation of its cultivation facility, resulting in a monthly profit of $25,000. The company successfully reduced its weekly debt repayments from $40,625 to $33,224, enabling nearly $30,000 in additional funds for operations. Despite a 4.9% sequential decline in revenue, SGA expenses decreased by 24%, indicating ongoing restructuring efforts. Furthermore, inventory values dropped by 43% YOY. While retail gross margins fell due to competitive pressures, wholesale margins improved by 9.5%. Looking ahead, Pervasip anticipates market strengthening in Q2, driven by decreasing bulk flower supply.